Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
- PMID: 6609824
- DOI: 10.1002/eji.1830140414
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
Abstract
Mice previously infected with an aerosol of A/Rec 31 influenza virus were strongly protected against an aerosol challenge with A/Vic influenza as judged by lung virus titers recovered 2 days after the challenge infection. Such complete homotypic immunity was not achieved by priming with live Rec 31 virus injected i.v. or UV-inactivated Rec 31 virus administered s.c. together with Al(OH)3 and saponin. The reason for the superior protective effect of the natural infection was investigated. The protection induced by respiratory infection with Rec 31 virus was specific for influenza A viruses. It was not correlated with specific serum hemagglutination inhibition antibody titer or cross-reactive cytotoxic T (Tc) cell reactivity. Moreover, the transfer of splenic and lymphoid T cell populations with strong secondary Tc activity did not significantly reduce lung virus titers in recipient mice 3 days after infection. The protection however occurred in parallel with the presence of cross-reactive IgA antibody in the lung washings. It thus appears that local secretory IgA plays a causal role in the prevention of cross-infection by influenza A virus. Serum antibody and Tc cells, on the other hand, may be crucial for recovery from such infection. All mice primed with live Rec 31 virus, administered i.v. or by aerosol and expressing equally high levels of Tc reactivity, survived a lethal challenge with A/PR8 virus. The same challenge, however, killed half of the mice immunized s.c. with inactivated Rec 31 virus which induced only a low level of Tc reactivity.
Similar articles
-
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.Eur J Immunol. 1991 Jun;21(6):1337-44. doi: 10.1002/eji.1830210602. Eur J Immunol. 1991. PMID: 1646112
-
Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.J Immunol. 1985 Feb;134(2):1230-5. J Immunol. 1985. PMID: 2981265
-
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.J Immunol. 1997 Feb 1;158(3):1222-30. J Immunol. 1997. PMID: 9013963
-
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.Jpn J Infect Dis. 2004 Dec;57(6):236-47. Jpn J Infect Dis. 2004. PMID: 15623947 Review.
-
Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.Jpn J Infect Dis. 2005 Aug;58(4):195-207. Jpn J Infect Dis. 2005. PMID: 16116250 Review.
Cited by
-
Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.J Virol. 2013 Jan;87(1):363-71. doi: 10.1128/JVI.02330-12. Epub 2012 Oct 17. J Virol. 2013. PMID: 23077318 Free PMC article.
-
PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs.Vet Microbiol. 2013 Sep 27;166(1-2):47-58. doi: 10.1016/j.vetmic.2013.04.029. Epub 2013 May 20. Vet Microbiol. 2013. PMID: 23764272 Free PMC article.
-
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.Infect Immun. 2000 Oct;68(10):5764-70. doi: 10.1128/IAI.68.10.5764-5770.2000. Infect Immun. 2000. PMID: 10992483 Free PMC article.
-
Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.Virol J. 2007 Oct 31;4:118. doi: 10.1186/1743-422X-4-118. Virol J. 2007. PMID: 17974006 Free PMC article.
-
Mucosal immunity: overcoming the barrier for induction of proximal responses.Immunol Res. 2004;30(1):35-71. doi: 10.1385/IR:30:1:035. Immunol Res. 2004. PMID: 15258310 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous